Literature DB >> 16205629

Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH.

K Ichimura1, A J Mungall, H Fiegler, D M Pearson, I Dunham, N P Carter, V Peter Collins.   

Abstract

Deletions of chromosome 6 are a common abnormality in diverse human malignancies including astrocytic tumours, suggesting the presence of tumour suppressor genes (TSG). In order to help identify candidate TSGs, we have constructed a chromosome 6 tile path microarray. The array contains 1,780 clones (778 P1-derived artificial chromosome and 1,002 bacterial artificial chromosome) that cover 98.3% of the published chromosome 6 sequences. A total of 104 adult astrocytic tumours (10 diffuse astrocytomas, 30 anaplastic astrocytomas (AA), 64 glioblastomas (GB)) were analysed using this array. Single copy number change was successfully detected and the result was in general concordant with a microsatellite analysis. The pattern of copy number change was complex with multiple interstitial deletions/gains. However, a predominance of telomeric 6q deletions was seen. Two small common and overlapping regions of deletion at 6q26 were identified. One was 1,002 kb in size and contained PACRG and QKI, while the second was 199 kb and harbours a single gene, ARID1B. The data show that the chromosome 6 tile path array is useful in mapping copy number changes with high resolution and accuracy. We confirmed the high frequency of chromosome 6 deletions in AA and GB, and identified two novel commonly deleted regions that may harbour TSGs. Oncogene (2006) 25, 1261-1271. doi:10.1038/sj.onc.1209156; published online 3 October 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16205629      PMCID: PMC2760128          DOI: 10.1038/sj.onc.1209156

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X.

Authors:  D R Bentley; P Deloukas; A Dunham; L French; S G Gregory; S J Humphray; A J Mungall; M T Ross; N P Carter; I Dunham; C E Scott; K J Ashcroft; A L Atkinson; K Aubin; D M Beare; G Bethel; N Brady; J C Brook; D C Burford; W D Burrill; C Burrows; A P Butler; C Carder; J J Catanese; C M Clee; S M Clegg; V Cobley; A J Coffey; C G Cole; J E Collins; J S Conquer; R A Cooper; K M Culley; E Dawson; F L Dearden; R M Durbin; P J de Jong; P D Dhami; M E Earthrowl; C A Edwards; R S Evans; C J Gillson; J Ghori; L Green; R Gwilliam; K S Halls; S Hammond; G L Harper; R W Heathcott; J L Holden; E Holloway; B L Hopkins; P J Howard; G R Howell; E J Huckle; J Hughes; P J Hunt; S E Hunt; M Izmajlowicz; C A Jones; S S Joseph; G Laird; C F Langford; M H Lehvaslaiho; M A Leversha; O T McCann; L M McDonald; J McDowall; G L Maslen; D Mistry; N K Moschonas; V Neocleous; D M Pearson; K J Phillips; K M Porter; S R Prathalingam; Y H Ramsey; S A Ranby; C M Rice; J Rogers; L J Rogers; T Sarafidou; D J Scott; G J Sharp; C J Shaw-Smith; L J Smink; C Soderlund; E C Sotheran; H E Steingruber; J E Sulston; A Taylor; R G Taylor; A A Thorpe; E Tinsley; G L Warry; A Whittaker; P Whittaker; S H Williams; T E Wilmer; R Wooster; C L Wright
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

2.  Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27.

Authors:  F Acquati; C Morelli; R Cinquetti; M G Bianchi; D Porrini; L Varesco; V Gismondi; R Rocchetti; S Talevi; L Possati; C Magnanini; M G Tibiletti; B Bernasconi; M G Daidone; V Shridhar; D I Smith; M Negrini; G Barbanti-Brodano; R Taramelli
Journal:  Oncogene       Date:  2001-02-22       Impact factor: 9.867

Review 3.  Fragile and unstable chromosomes in cancer: causes and consequences.

Authors:  R I Richards
Journal:  Trends Genet       Date:  2001-06       Impact factor: 11.639

4.  The complexity of the 7p12 amplicon in human astrocytic gliomas: detailed mapping of 246 tumors.

Authors:  L Liu; K Ichimura; E H Pettersson; H M Goike; V P Collins
Journal:  J Neuropathol Exp Neurol       Date:  2000-12       Impact factor: 3.685

5.  Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

Authors:  K Ichimura; M B Bolin; H M Goike; E E Schmidt; A Moshref; V P Collins
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

6.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 7.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

8.  Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.

Authors:  R Büschges; R G Weber; B Actor; P Lichter; V P Collins; G Reifenberger
Journal:  Brain Pathol       Date:  1999-07       Impact factor: 6.508

9.  Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.

Authors:  T Sonoki; L Harder; D E Horsman; L Karran; I Taniguchi; T G Willis; S Gesk; D Steinemann; E Zucca; B Schlegelberger; F Solé; A J Mungall; R D Gascoyne; R Siebert; M J Dyer
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

10.  Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.

Authors:  A Miyakawa; K Ichimura; E E Schmidt; S Varmeh-Ziaie; V P Collins
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more
  29 in total

1.  Construction and use of spotted large-insert clone DNA microarrays for the detection of genomic copy number changes.

Authors:  Heike Fiegler; Richard Redon; Nigel P Carter
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

2.  The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein.

Authors:  Yi Zhao; Gen Zhang; Mengying Wei; Xiaozhao Lu; Hanyan Fu; Feixue Feng; Shan Wang; Wei Lu; Ning Wu; Zifan Lu; Jianlin Yuan
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742

3.  Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.

Authors:  Xu Zhang; Haiying Jia; Yao Lu; Chengliang Dong; Jinghui Hou; Zheng Wang; Feng Wang; Hongbin Zhong; Lin Wang; Kai Wang
Journal:  Discov Med       Date:  2014-12       Impact factor: 2.970

4.  PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Authors:  George Poulogiannis; Rebecca E McIntyre; Maria Dimitriadi; John R Apps; Catherine H Wilson; Koichi Ichimura; Feijun Luo; Lewis C Cantley; Andrew H Wyllie; David J Adams; Mark J Arends
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

5.  Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Giacomo Diaz; Marta Melis; Ashley Tice; David E Kleiner; Lopa Mishra; Fausto Zamboni; Patrizia Farci
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

6.  The QKI-5 and QKI-6 RNA binding proteins regulate the expression of microRNA 7 in glial cells.

Authors:  Yunling Wang; Gillian Vogel; Zhenbao Yu; Stéphane Richard
Journal:  Mol Cell Biol       Date:  2013-01-14       Impact factor: 4.272

7.  RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.

Authors:  Guodong Yang; Haiyan Fu; Jie Zhang; Xiaozhao Lu; Fang Yu; Liang Jin; Liyuan Bai; Bo Huang; Lan Shen; Yue Feng; Libo Yao; Zifan Lu
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

8.  1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.

Authors:  K Ichimura; A P Vogazianou; L Liu; D M Pearson; L M Bäcklund; K Plant; K Baird; C F Langford; S G Gregory; V P Collins
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

9.  Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development.

Authors:  Katrina Bockbrader; Yue Feng
Journal:  Future Neurol       Date:  2008-11

10.  Genome-wide analysis of subependymomas shows underlying chromosomal copy number changes involving chromosomes 6, 7, 8 and 14 in a proportion of cases.

Authors:  Kathreena M Kurian; David T W Jones; Faye Marsden; Sam W S Openshaw; Danita M Pearson; Koichi Ichimura; V Peter Collins
Journal:  Brain Pathol       Date:  2008-04-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.